Show Notes
Dr. Riley Kirk welcomes Dr. Miyabe Shields for a deep dive into cannabis real-world data, cannabis consumption patterns, dosing, neurodivergent cannabis use, and the Endocannabinoid System (ECS). As co-founders of the Network of Applied Pharmacognosy (NAP), Riley and Miyabe discuss the newly accessible Real Data Project, including what large-scale consumer data can reveal about how people actually use cannabis in their everyday lives.
They explore why terms like “heavy cannabis consumption” are difficult to define, how consumption can vary by dose and frequency, and what the data shows across different populations and consumption methods. They also discuss the importance of making real-world cannabis data accessible to consumers, researchers, patients, and healthcare professionals rather than keeping it behind academic paywalls or within highly controlled research settings.
The conversation also covers cannabis and neurodivergence, cannabis and mental health, the challenges of interpreting cannabis research, product chemistry and consumer experiences, terpene levels, cannabis aging, and how chemical data can eventually be connected with the way individual consumers actually feel after using a product.
Finally, Riley and Miyabe discuss their ECS-focused e-book, created to make information about the Endocannabinoid System more accessible to both new and experienced cannabis consumers, including practical information about dosing, lifestyle, sleep, exercise, diet, and understanding your own ECS.
Chapters
00:00 Giveaway!
00:53 Welcome to another NAP Time episode
01:27 What is the Real Data Project?
03:00 Why “heavy cannabis consumption” is difficult to define
04:25 Dose, frequency, and different types of cannabis consumers
06:05 What the consumption data is beginning to reveal
09:20 Real-world data on cannabis-infused beverages
11:39 Cannabis use and neurodivergent populations
14:27 What the data can and cannot tell us
17:45 Cannabis research, stigma, and risk factors
19:13 Barriers to cannabis as medicine
23:09 Real-world data vs. clinical trials and meta-analyses
29:45 Why cannabis chemistry alone doesn't tell the whole story
34:41 Making cannabis data accessible to everyone
39:00 How cannabis aroma preferences change over time
41:26 Terpenes, harshness, and the importance of mouthfeel
47:49 Connecting product chemistry with real-world effects
49:15 What happens to cannabis as it ages?
51:46 Explore the Real Data Project
52:26 A new Endocannabinoid System e-book
58:14 Building research with community feedback
59:06 What Miyabe and Riley are consuming right now
01:02:14 Final thoughts
Resources
Explore the Real Data Project / RWD Exchange:
Network of Applied Pharmacognosy (NAP):
https://www.appliedpharmacognosy.org/
E-book Update
We really hope the e-book is ready by the time this episode airs, but we’re still working on finalizing the graphics! Once the e-book is ready, we’ll announce it on the podcast and through Patreon, so be sure to stay tuned for the official release.
Enter the Storz & Bickel VZ Giveaway:
https://forms.gle/gBLCEem9BwherVdYA
Connect With Dr. Miyabe Shields on LinkedIn:
https://www.linkedin.com/in/miyabeshields
Want Exclusive Content and ad-free episodes?
Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one.
www.Patreon.com/Cannabichem
Don’t forget to like, subscribe, and hit the notification bell for more expert insights into cannabis science, plant biology, natural products, and more!
Sign Up for Emails!
www.AppliedPharmacognosy.org
Keep up with Dr. Riley Kirk:
https://www.bioactivepodcast.com/
https://www.youtube.com/@cannabichem
https://instagram.com/cannabichem
https://www.appliedpharmacognosy.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices
More from BIOACTIVE
What are cannabis terpenes, how do they influence aroma and consumer experiences, and what do we know about their safety? On this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Shawna Vreeke, PhD, DABT, Head of Toxicology at True Terpenes, to explore the science of cannabis terpenes, terpene chemistry, cannabinoid interactions, and consumer safety. With a PhD in Chemistry focused on toxin formation in vape device aerosols and expertise in toxicology risk assessment, Shawna shares insights into what current research tells us about terpenes and where important questions remain unanswered.
What if carbon is one of the most overlooked inputs in plant nutrition? In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Nik Nikolayev, CEO of Rooted Leaf Agritech, to explore the science of carbon-based fertilizers, plant nutrition, biostimulants, organic acids, and the chemistry behind plant growth, yield, and quality.
Dr. Riley Kirk has Dr. Denise Valenti on the podcast to discuss cannabis and driving, cannabis impairment, THC testing, and the challenges of determining whether someone is actually too impaired to drive. They explore why THC levels in the body do not necessarily correspond to impairment and how cannabis can affect vision, peripheral vision, contrast sensitivity, eye movement, balance, and pupil response.
In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Rick Pescatore, board-certified emergency physician, Editor-in-Chief of Emergency Medicine News, and founder of BellyMD, for a fascinating deep dive into the gut-brain connection and what it means for cannabis users and patients dealing with unexplained digestive symptoms.
What actually happened inside the DEA’s cannabis rescheduling hearing? In this timely episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Max Jackson, former commercial cannabis cultivator and founder of Cannabis Wise Guys, to unpack what he witnessed firsthand at the DEA hearing on moving cannabis from Schedule I to Schedule III.